EXHIBIT 8
Dr. Reddy’s Laboratories Limited
Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries, joint ventures and associates as of March 31, 2024:
Name of the subsidiary/joint venture/associate | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. | Malaysia | 100%(3) |
Aurigene Oncology Limited (formerly Aurigene Discovery Technologies Limited) | India | 100% |
Aurigene Pharmaceutical Services Limited | India | 100%(3) |
beta Institut gemeinnützige GmbH | Germany | 100%(7) |
betapharm Arzneimittel GmbH | Germany | 100%(7) |
Cheminor Investments Limited | India | 100% |
Cheminor Employees Welfare Trust | India | Refer to below footnote(13) |
Chirotech Technology Limited | United Kingdom | 100%(2)(5) |
Dr. Reddy’s Research Foundation | India | Refer to below footnote(13) |
Dr. Reddy's Employees ESOS Trust | India | Refer to below footnote(13) |
Dr. Reddy’s Farmaceutica Do Brasil Ltda. | Brazil | 100% |
Dr. Reddy’s Laboratories (EU) Limited | United Kingdom | 100%(8) |
Dr. Reddy’s Laboratories (Proprietary) Limited | South Africa | 100%(8) |
Dr. Reddy’s Laboratories (UK) Limited | United Kingdom | 100%(5) |
Dr. Reddy’s Laboratories Canada, Inc. | Canada | 100%(8) |
Dr. Reddy's Laboratories Chile SPA. | Chile | 100%(8) |
Dr. Reddy’s Laboratories, Inc. | U.S.A. | 100%(8) |
Dr. Reddy’s Laboratories Japan KK | Japan | 100%(8) |
Dr. Reddy’s Laboratories Kazakhstan LLP | Kazakhstan | 100%(8) |
Dr. Reddy’s Laboratories Louisiana, LLC | U.S.A. | 100%(1) |
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. | Malaysia | 100%(8) |
Dr. Reddy’s Laboratories New York, LLC | U.S.A. | 100%(1) |
Dr. Reddy’s Laboratories Philippines Inc. | Philippines | 100%(8) |
Dr. Reddy’s Laboratories Romania S.R.L. | Romania | 100%(8) |
Dr. Reddy’s Laboratories SA | Switzerland | 100% |
Dr. Reddy’s Laboratories Taiwan Limited | Taiwan | 100%(8) |
Dr. Reddy’s Laboratories (Thailand) Limited | Thailand | 100%(8) |
Dr. Reddy’s Laboratories LLC | Russia | 100%(8) |
Dr. Reddy’s Laboratories, LLC | Ukraine | 100%(8) |
Dr. Reddy’s New Zealand Limited | New Zealand | 100%(8) |
Dr. Reddy’s S.R.L. | Italy | 100%(9) |
Dr. Reddy’s Bio-Sciences Limited | India | 100% |
Dr. Reddy’s Laboratories (Australia) Pty. Limited | Australia | 100%(8) |
Dr. Reddy’s Laboratories S.A.S. | Colombia | 100%(8) |
Dr. Reddy’s Research and Development B.V. | Netherlands | 100%(10) |
Dr. Reddy’s Venezuela, C.A. | Venezuela | 100%(8)(14) |
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited | China | 100%(8) |
Dr. Reddy’s Laboratories Jamaica Limited (from September 25, 2023) | Jamaica | 100% |
Dr. Reddy’s Nutraceuticals Limited (from March 14, 2024) | India | 100% |
DRES Energy Private Limited | India | 26%(12) |
DRL Impex Limited | India | 100%(11) |
Dr. Reddy’s Formulations Limited | India | 100% |
Idea2Enterprises (India) Private Limited | India | 100% |
Imperial Owners and Land Possessions Private Limited (Formerly, Imperial Credit Private Limited) | India | 100% |
Industrias Quimicas Falcon de Mexico, S.A. de CV | Mexico | 100% |
Kunshan Rotam Reddy Pharmaceutical Co. Limited | China | 51.33%(4) |
Lacock Holdings Limited | Cyprus | 100%(8) |
Nimbus Health, GmbH | Germany | 100%(7) |
Organizational structure (continued) |
|
|
Name of the subsidiary/joint venture/associate | Country of Incorporation | Percentage of Direct/Indirect Ownership Interest |
O2 Renewable Energy IX Private Limited | India | 26%(12) |
Promius Pharma, LLC | U.S.A. | 100%(1) |
Reddy Holding GmbH | Germany | 100%(8) |
Reddy Netherlands B.V. | Netherlands | 100%(8) |
Reddy Pharma Iberia S.A.U. | Spain | 100%(8) |
Reddy Pharma Italia S.R.L. | Italy | 100%(6) |
Reddy Pharma SAS | France | 100%(8) |
SVAAS Wellness Limited | India | 100% |
(1) | Indirectly owned through Dr. Reddy’s Laboratories, Inc. |
(2) | Entity under liquidation. |
(3) | Indirectly owned through Aurigene Oncology Limited. |
(4) | Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as per the Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements. |
(5) | Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited. |
(6) | Indirectly owned through Lacock Holdings Limited. |
(7) | Indirectly owned through Reddy Holding GmbH. |
(8) | Indirectly owned through Dr. Reddy’s Laboratories SA. |
(9) | Indirectly owned through Reddy Pharma Italia S.R.L. |
(10) | Indirectly owned through Reddy Netherlands B.V. |
(11) | Indirectly owned through Idea2Enterprises (India) Pvt. Limited. |
(12) | Accounted using equity method as per IAS 28 “Investments in Associates and Joint ventures.” |
(13) | The Company does not have any equity interests in this entity, but has significant influence or control over it. |
(14) | The Company disposed of its entire stake in this entity subsequently on April 17, 2024. |